Curnutte John T 4
4 · PLIANT THERAPEUTICS, INC. · Filed Jun 8, 2023
Insider Transaction Report
Form 4
Curnutte John T
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-06-07+14,000→ 14,000 totalExercise: $23.09Exp: 2033-06-07→ Common Stock (14,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter for three calendar quarters following the June 7th, 2023 grant date and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of the June 7th, 2023 grant date, or (ii) the 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service to the Issuer as a Director through each such date or, if earlier, such annual meeting.